A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 30,571 shares of HRMY stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,571
Previous 46,125 33.72%
Holding current value
$1.04 Million
Previous $1.39 Million 12.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$30.0 - $39.95 $466,620 - $621,382
-15,554 Reduced 33.72%
30,571 $1.22 Million
Q2 2024

Jul 19, 2024

BUY
$28.81 - $33.01 $469,833 - $538,327
16,308 Added 54.69%
46,125 $1.39 Million
Q1 2024

Apr 22, 2024

BUY
$29.93 - $35.06 $892,422 - $1.05 Million
29,817 New
29,817 $1 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.